BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3902675)

  • 1. Ambulatory monitoring and exercise testing in the evaluation of a new long-acting calcium ion antagonist KB-944 (Fostedil) for the treatment of exertional angina pectoris.
    Khurmi NS; Bowles MJ; O'Hara MJ; Lahiri A; Raftery EB
    Int J Cardiol; 1985 Nov; 9(3):289-302. PubMed ID: 3902675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short- and long-term efficacy of nicardipine, assessed by placebo-controlled single- and double-blind crossover trials in patients with chronic stable angina.
    Khurmi NS; Bowles MJ; Bala Subramanian V; Raftery EB
    J Am Coll Cardiol; 1984 Nov; 4(5):908-17. PubMed ID: 6386933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Objective evaluation of PY-108-068, a new calcium channel inhibitor for the treatment of chronic stable angina pectoris.
    O'Hara MJ; Khurmi NS; Bowles MJ; Raftery EB
    Eur Heart J; 1985 Aug; 6(8):689-94. PubMed ID: 4054138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of once daily penbutolol in chronic stable angina. An objective comparison with long-acting propranolol.
    Bowles MJ; Khurmi NS; Bala Subramanian V; Raftery EB
    Int J Cardiol; 1984 Feb; 5(2):131-42. PubMed ID: 6365803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diltiazem, nifedipine, and their combination in patients with stable angina pectoris: effects on angina, exercise tolerance, and the ambulatory electrocardiographic ST segment.
    Frishman W; Charlap S; Kimmel B; Teicher M; Cinnamon J; Allen L; Strom J
    Circulation; 1988 Apr; 77(4):774-86. PubMed ID: 3280158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of bevantolol for chronic, stable angina pectoris.
    Bowles MJ; Khurmi NS; O'Hara MJ; Raftery EB
    Am J Cardiol; 1986 Nov; 58(12):28E-34E. PubMed ID: 2878598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of bepridil for the treatment of angina pectoris: evidence for preservation of left ventricular function.
    Zusman RM; Christensen DM; Kanarek DJ; Kiess MC; Boucher CA
    Am J Cardiol; 1985 Mar; 55(7):30C-35C. PubMed ID: 3919555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antianginal efficacy and improved exercise performance with timolol. Twice-daily beta blockade in ischemic heart disease.
    Harris FJ; Low RI; Paumer L; Amsterdam EA; Mason DT
    Am J Cardiol; 1983 Jan; 51(1):13-8. PubMed ID: 6129794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of negative inotropic effects of the new calcium antagonist Ro 40-5967 in patients with stable angina pectoris.
    Portegies MC; Schmitt R; Kraaij CJ; Braat SH; Gassner A; Hagemeijer F; Pozenel H; Prager G; Viersma JW; van der Wall EE
    J Cardiovasc Pharmacol; 1991 Nov; 18(5):746-51. PubMed ID: 1723772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-blind, dose-response, placebo-controlled multicenter study of nisoldipine. A new second-generation calcium channel blocker in angina pectoris.
    Thadani U; Zellner SR; Glasser S; Bittar N; Montoro R; Miller AB; Chaitman B; Schulman P; Stahl A; DiBianco R
    Circulation; 1991 Dec; 84(6):2398-408. PubMed ID: 1959195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy of the addition of nifedipine in patients with mixed angina compared to patients with classic exertional angina: a multicenter, randomized, double-blind, placebo-controlled clinical trial.
    Stone PH; Ware JH; DeWood MA; Gore JM; Eich RH; Pietro DA; Parisi AF; Nesto RW; Boden WE; Sharma SC
    Am Heart J; 1988 Oct; 116(4):961-71. PubMed ID: 2902779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of bepridil on exercise tolerance in chronic stable angina: a double-blind, randomized, placebo-controlled, crossover trial.
    Hill JA; O'Brien JT; Scott E; Conti CR; Pepine CJ
    Am J Cardiol; 1984 Mar; 53(6):679-83. PubMed ID: 6367414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beneficial effects of high-dose diltiazem in patients with persistent effort angina on beta-blockers and nitrates: a randomized, double-blind, placebo-controlled cross-over study.
    Boden WE; Bough EW; Reichman MJ; Rich VB; Young PM; Korr KS; Shulman RS
    Circulation; 1985 Jun; 71(6):1197-205. PubMed ID: 2859931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized double-blind placebo-controlled comparison of nicardipine and nifedipine in patients with chronic stable angina pectoris.
    Bowles MJ; Khurmi NS; O'Hara MJ; Raftery EB
    Chest; 1986 Feb; 89(2):260-5. PubMed ID: 3510823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of PY 108-068, a new calcium channel blocker, for angina pectoris.
    de Buitleir M; Krikler S; Krikler DM
    Am J Cardiol; 1986 Jan; 57(1):15-9. PubMed ID: 3079940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of controlled-onset, extended-release verapamil with amlodipine and amlodipine plus atenolol on exercise performance and ambulatory ischemia in patients with chronic stable angina pectoris.
    Frishman WH; Glasser S; Stone P; Deedwania PC; Johnson M; Fakouhi TD
    Am J Cardiol; 1999 Feb; 83(4):507-14. PubMed ID: 10073852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of propranolol, diltiazem, and nifedipine in the treatment of ambulatory ischemia in patients with stable angina. Differential effects on ambulatory ischemia, exercise performance, and anginal symptoms. The ASIS Study Group.
    Stone PH; Gibson RS; Glasser SP; DeWood MA; Parker JD; Kawanishi DT; Crawford MH; Messineo FC; Shook TL; Raby K
    Circulation; 1990 Dec; 82(6):1962-72. PubMed ID: 2122926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized double-blind comparison of gallopamil and propranolol in stable angina pectoris.
    Khurmi NS; O'Hara MJ; Bowles MJ; Subramanian VB; Raftery EB
    Am J Cardiol; 1984 Mar; 53(6):684-8. PubMed ID: 6367415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antianginal efficacy and safety of ivabradine compared with amlodipine in patients with stable effort angina pectoris: a 3-month randomised, double-blind, multicentre, noninferiority trial.
    Ruzyllo W; Tendera M; Ford I; Fox KM
    Drugs; 2007; 67(3):393-405. PubMed ID: 17335297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative antianginal effects of bepridil and propranolol in angina pectoris.
    Parker JO; Farrell B
    Am J Cardiol; 1986 Sep; 58(6):449-52. PubMed ID: 3529909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.